MDGL
MDGL
NASDAQ · Biotechnology

Madrigal Pharmaceuticals Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$510.04
-0.32 (-0.06%)
As of Aug 8, 9:44 PM ET ·
Analyst Consensus
Strong Buy
24
Analysts
High
Coverage
Buy 21 88%
Hold 3 13%
Sell 0 0%
Price Target
Analyst Price Target -76.5% upside
Low Target $78.20
Average Target $119.83
High Target $127.79
Current Price $510.04
Current
$510.04
Target
$119.83
$78.20 $119.83 avg $127.79
Scenario Analysis
Bear Case
$78.20
-84.7%
Low target
Base Case
$119.83
-76.5%
Avg target
Bull Case
$127.79
+-74.9%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$615.00
-17.1% from high
52-Week Low
$331.00
+54.1% from low
50-Day SMA
$526.21
-3.1% vs SMA
200-Day SMA
$421.32
+21.1% vs SMA
RSI (14)
32.6
Neutral
Target vs 52W High
$119.83
-80.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.0%